Cargando…
Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes
A lack of stratification methods in patients with amyotrophic lateral sclerosis (ALS) is likely implicated in therapeutic failures. Regional diversities and pathophysiological abnormalities in astrocytes from mice with SOD1 mutations (mSOD1-ALS) can now be explored in human patients using somatic ce...
Autores principales: | Gomes, Cátia, Sequeira, Catarina, Likhite, Shibi, Dennys, Cassandra N., Kolb, Stephen J., Shaw, Pamela J., Vaz, Ana R., Kaspar, Brian K., Meyer, Kathrin, Brites, Dora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997588/ https://www.ncbi.nlm.nih.gov/pubmed/35406750 http://dx.doi.org/10.3390/cells11071186 |
Ejemplares similares
-
Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons
por: Barbosa, Marta, et al.
Publicado: (2021) -
Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons
por: Haidet-Phillips, Amanda M., et al.
Publicado: (2011) -
The Evolving Landscape of Neurotoxicity by Unconjugated Bilirubin: Role of Glial Cells and Inflammation
por: Brites, Dora
Publicado: (2012) -
MHC class I protects motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis (ALS)
por: Song, SungWon, et al.
Publicado: (2016) -
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease
por: Johnson, Tyler B., et al.
Publicado: (2023)